Quality Of Life

AUSTIN, Texas — Treatment with 10 mg zavegepant nasal spray resulted in better quality of life as early as 12 weeks and through 1 year in adult patients with migraine, according to research presented here.

Unlike other assessments, the Food Allergy Satisfaction with Life Scale assesses how individuals impacted by food allergy cognitively evaluate their own lives, according to a letter published in Clinical and Translational Allergy.

WASHINGTON — At 52 weeks, adults with moderate/severe COPD and type 2 inflammation receiving dupilumab had a lower exacerbation rate and better lung function, according to an American Thoracic Society International Conference presentation.

Results showed patients who had periprosthetic joint infection after total joint arthroplasty may have difficulty performing everyday tasks and returning to work.

AUSTIN, Texas — Atogepant significantly improved daily functioning and reduced physical impairment in adults with chronic migraine within 1 week of treatment, according to study results presented here by Jessica Ailani, MD.

For patients with COPD hospitalized with acute exacerbations, pulmonary rehabilitation yielded better exercise capacity and quality of life vs. usual care, according to study results published in Annals of the American Thoracic Society.

For survivors of serious COVID-19, a physical activity program was a safe, effective intervention for improving health-related quality of life, persistent symptoms and more, according to the results of a randomized controlled trial.

Parents of children receiving pediatric palliative care named quality of life as the most important goal of that care, according to a study published in JAMA Pediatrics.

The prospect of managing a lifelong disease can be daunting, and many patients with chronic conditions struggle with consistent health monitoring, treatment adherence and implementing the changes needed to manage their disease.

WASHINGTON — Patients with COPD who also have depression and/or anxiety may not be receiving the treatment they need due to their respiratory disease, according to a presentation at the American Thoracic Society International Conference.